Do you have melasma or any other form of stubborn hyperpigmentation on your face or elsewhere on your body? Have you tried all available conventional treatments and spent a small fortune, only for the dark patches to remain steadfast if not worsen? Are you lacking in confidence socially? Are you afraid to go outdoors to bask in the sunshine? Are you embarrassed, depressed or frustrated about having this disease? Then why not try out a new method of treatment that has so far yielded exciting and promising results? This therapy is safe, inexpensive and rewarding, and has been proven to work for many sufferers via an ongoing experiment that I initiated in January 2002. Just 7 months later, approximately 100 women were reaping the benefits of supplementing their diets with a remarkable nutrient called MSM Sulphur...could this be the clear solution for you too?

Abstract: Background Long-term data (>10 years) concerning the survival and success rates of implants and implant-supported prostheses are scarce. Purpose The present investigation represents one of the first studies on dental implants covering an observational period of 25 years. Materials and methods This study presents the results obtained in 26 patients with 75 implants who participated over a 23- to 28-year period in a supportive implant therapy (SIT) program at a private dental practice. We extracted existing data from the patients' files (pocket depths [PDs], bleeding on probing [BoP], radiographic peri-implant bone loss, and survival rates of the implant-supported prostheses). Results After 25 years, the SIT-compliant patients' implants had a survival rate of 95% (prostheses: 88%). The mean peri-implant probing depth was 3.69 mm (median: 3.33; SD: 1.06; range: 2-8.33). The mean peri-implant bone level was 1.84 mm (median: 1.82; SD: 1.20; range: −0.97-5.2). Finally, the prevalence (moment of last consultation) and incidence (during the entire observational period) of peri-implantitis were 7% and 30%, respectively. Conclusions Under SIT conditions, clinicians may expect survival rates for implant-supported prostheses of >80%. Most implants (60%) did not develop signs of peri-implantitis over a 25-year period